ENST00000498603.5:c.-235G>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000498603.5(SEC61B):​c.-235G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0665 in 678,348 control chromosomes in the GnomAD database, including 1,742 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.059 ( 334 hom., cov: 32)
Exomes 𝑓: 0.069 ( 1408 hom. )

Consequence

SEC61B
ENST00000498603.5 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.09

Publications

3 publications found
Variant links:
Genes affected
SEC61B (HGNC:16993): (SEC61 translocon subunit beta) The Sec61 complex is the central component of the protein translocation apparatus of the endoplasmic reticulum (ER) membrane. Oligomers of the Sec61 complex form a transmembrane channel where proteins are translocated across and integrated into the ER membrane. This complex consists of three membrane proteins- alpha, beta, and gamma. This gene encodes the beta-subunit protein. The Sec61 subunits are also observed in the post-ER compartment, suggesting that these proteins can escape the ER and recycle back. There is evidence for multiple polyadenylated sites for this transcript. [provided by RefSeq, Jul 2008]
ALG2 (HGNC:23159): (ALG2 alpha-1,3/1,6-mannosyltransferase) This gene encodes a member of the glycosyltransferase 1 family. The encoded protein acts as an alpha 1,3 mannosyltransferase, mannosylating Man(2)GlcNAc(2)-dolichol diphosphate and Man(1)GlcNAc(2)-dolichol diphosphate to form Man(3)GlcNAc(2)-dolichol diphosphate. Defects in this gene have been associated with congenital disorder of glycosylation type Ih (CDG-Ii). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]
ALG2 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 14
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • ALG2-congenital disorder of glycosylation
    Inheritance: Unknown, AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, PanelApp Australia, Orphanet, Ambry Genetics
  • congenital myasthenic syndromes with glycosylation defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.077 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG2NM_033087.4 linkc.-202C>G upstream_gene_variant ENST00000476832.2 NP_149078.1 Q9H553-1A0A024R184
SEC61BNM_006808.3 linkc.-268G>C upstream_gene_variant ENST00000223641.5 NP_006799.1 P60468
ALG2NR_024532.2 linkn.-154C>G upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG2ENST00000476832.2 linkc.-202C>G upstream_gene_variant 1 NM_033087.4 ENSP00000417764.1 Q9H553-1
SEC61BENST00000223641.5 linkc.-268G>C upstream_gene_variant 1 NM_006808.3 ENSP00000223641.4 P60468

Frequencies

GnomAD3 genomes
AF:
0.0589
AC:
8970
AN:
152176
Hom.:
334
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0303
Gnomad AMI
AF:
0.187
Gnomad AMR
AF:
0.0620
Gnomad ASJ
AF:
0.0519
Gnomad EAS
AF:
0.00924
Gnomad SAS
AF:
0.0599
Gnomad FIN
AF:
0.0548
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0787
Gnomad OTH
AF:
0.0621
GnomAD4 exome
AF:
0.0687
AC:
36145
AN:
526054
Hom.:
1408
Cov.:
6
AF XY:
0.0687
AC XY:
18734
AN XY:
272830
show subpopulations
African (AFR)
AF:
0.0296
AC:
408
AN:
13776
American (AMR)
AF:
0.0626
AC:
1176
AN:
18776
Ashkenazi Jewish (ASJ)
AF:
0.0477
AC:
675
AN:
14162
East Asian (EAS)
AF:
0.00915
AC:
287
AN:
31360
South Asian (SAS)
AF:
0.0643
AC:
3025
AN:
47074
European-Finnish (FIN)
AF:
0.0552
AC:
1637
AN:
29676
Middle Eastern (MID)
AF:
0.0665
AC:
142
AN:
2134
European-Non Finnish (NFE)
AF:
0.0790
AC:
26906
AN:
340484
Other (OTH)
AF:
0.0660
AC:
1889
AN:
28612
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1905
3809
5714
7618
9523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0589
AC:
8973
AN:
152294
Hom.:
334
Cov.:
32
AF XY:
0.0575
AC XY:
4283
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0303
AC:
1261
AN:
41566
American (AMR)
AF:
0.0617
AC:
945
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0519
AC:
180
AN:
3466
East Asian (EAS)
AF:
0.00926
AC:
48
AN:
5184
South Asian (SAS)
AF:
0.0595
AC:
287
AN:
4824
European-Finnish (FIN)
AF:
0.0548
AC:
582
AN:
10614
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0787
AC:
5356
AN:
68018
Other (OTH)
AF:
0.0614
AC:
130
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
456
913
1369
1826
2282
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0116
Hom.:
4
Bravo
AF:
0.0585
Asia WGS
AF:
0.0430
AC:
149
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.27
DANN
Benign
0.49
PhyloP100
-1.1
PromoterAI
0.058
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41274648; hg19: chr9-101984378; API